Cameron Bradshaw

Cameron Bradshaw has over nine years of experience in finance and business development. Currently serving as the Director of Business Development at Neurocrine Biosciences since November 2018, Cameron previously worked as an Equity Research Analyst at Bank of America Merrill Lynch for one year and held a similar role at Goldman Sachs for nearly four years prior. This extensive background in equity research and business development positions Cameron as a knowledgeable professional in the industry.